Palma, Baby Boy .
HRN: 24-06-56 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/16/2023
01/16/2024
IV
380mg
Q12
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes